AI Verdict
IRWD has stronger fundamentals based on our AI analysis.
ISCO vs IRWD Fundamental Comparison
| Metric | ISCO | IRWD |
|---|---|---|
| Revenue | $6.9M | $296.2M |
| Net Income | $-70,000.0 | $24.0M |
| Net Margin | -1.0% | 8.1% |
| ROE | N/A | N/A |
| ROA | -1.3% | 6.1% |
| Current Ratio | 0.80x | 1.13x |
| Debt/Equity | N/A | N/A |
| EPS | $-0.01 | $0.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ISCO vs IRWD: Frequently Asked Questions
Is ISCO or IRWD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IRWD has stronger fundamentals. ISCO is rated STRONG SELL (92% confidence) while IRWD is rated HOLD (62% confidence). This is not investment advice.
How does ISCO compare to IRWD fundamentally?
International Stem Cell CORP has ROE of N/A vs IRONWOOD PHARMACEUTICALS INC's N/A. Net margins are -1.0% vs 8.1% respectively.
Which stock pays higher dividends, ISCO or IRWD?
ISCO has a dividend yield of N/A or no dividend while IRWD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ISCO or IRWD for long term?
For long-term investing, consider that ISCO has STRONG SELL rating with 92% confidence, while IRWD has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ISCO vs IRWD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISCO vs IRWD, the AI consensus favors IRWD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.